Skip to main content

Table 1 Baseline characteristics of participants grouped by quintile of SHR a,b

From: Prognostic significance of the stress hyperglycemia ratio and admission blood glucose in diabetic and nondiabetic patients with spontaneous intracerebral hemorrhage

Variables

Total

(n = 1028)

Q1

(n = 205)

Q2

(n = 204)

Q3

(n = 209)

Q4

(n = 204)

Q5

(n = 206)

p-value

 

Age, years

71.09 (60.05, 81.97)

72.1 (62.44, 82.39)

72.96 (62.34, 82.28)

72.69 (63.21, 84.18)

67.81 (56.2, 79.31)

68.73 (56.89, 77.79)

< 0.001

Male, n%

548 (53)

108 (53)

113 (55)

120 (57)

114 (56)

93 (45)

0.097

GCS

14 (12, 15)

14 (13, 15)

14 (12, 15)

14 (11, 15)

14 (12, 15)

14 (11, 15)

0.332

Severe Score

       

 APSIII

34 (25, 44)

32 (24, 43)

30 (21.75, 40)

34 (26, 44)

34 (26, 45)

40.5 (31, 51)

< 0.001

 SAPSII

31 (25, 39)

31 (25, 40)

30 (24, 37)

30 (24, 36)

31 (24, 38)

35 (28, 41)

< 0.001

 SOFA

3 (1, 4)

2 (1, 4)

2 (1, 4)

2 (1, 4)

3 (1, 4)

4 (2, 5)

< 0.001

 OASIS

30 (26, 36)

29 (25, 35)

29 (24, 34)

30 (26, 35)

30 (26, 35)

33 (28, 38)

< 0.001

Comorbidities, n(%)

       

 MI

95 (9)

19 (9)

22 (11)

18 (9)

10 (5)

26 (13)

0.089

 CHF

157 (15)

36 (18)

33 (16)

30 (14)

25 (12)

33 (16)

0.623

 Diabetes

304 (30)

72 (35)

48 (24)

52 (25)

44 (22)

88 (43)

< 0.001

 Renal disease

128 (12)

34 (17)

22 (11)

28 (13)

19 (9)

25 (12)

0.217

 RD

16 (2)

4 (2)

2 (1)

4 (2)

0 (0)

6 (3)

0.108

 PVD

70 (7)

17 (8)

15 (7)

17 (8)

14 (7)

7 (3)

0.271

 CPD

120 (12)

26 (13)

19 (9)

24 (11)

20 (10)

31 (15)

0.37

 Hypertension

275 (27)

60 (29)

64 (31)

58 (28)

52 (25)

41 (20)

0.088

Vital signs

       

 Mean HR (min− 1)

78.2 (70.06, 87.87)

73.27 (66.88, 82.84)

74.78 (68.95, 84.37)

79.06 (70.29, 87.62)

80.96 (72, 89.73)

84 (74.14, 94.42)

< 0.001

 Mean AP (mmHg)

85.83 ± 10.03

85.96 ± 9.95

86.77 ± 9.19

86.64 ± 10.7

86.08 ± 10.29

83.72 ± 9.74

0.015

 Mean RR (min− 1)

18.35 (16.79, 20.21)

18.1 (16.5, 19.68)

18.12 (16.54, 20.21)

18.42 (16.94, 19.88)

18.44 (16.31, 20.72)

18.72 (17.29, 20.64)

0.033

 Mean Temp (°C)

36.94 (36.73, 37.24)

36.87 (36.69, 37.1)

36.92 (36.73, 37.22)

36.95 (36.73, 37.24)

37 (36.78, 37.28)

36.99 (36.77, 37.36)

0.001

 Mean SpO2 (%)

97.08 (95.92, 98.34)

96.93 (96.05, 98)

96.9 (95.8, 98.08)

96.9 (95.72, 98.23)

97.42 (96.16, 98.38)

97.72 (95.89, 98.96)

0.004

Laboratory test

       

 WBC (K/uL)

9.95 (7.93, 12.78)

9.75 (7.9, 12.43)

10.22 (8.11, 13.04)

10.05 (8.07, 12.61)

10.2 (8.18, 12.93)

9.78 (7.51, 12.49)

0.233

 Neutrophils (%)

79.9 (70.35, 85.8)

80 (69.42, 86.14)

80.5 (70.47, 86.21)

78.3 (70.25, 84.3)

81.6 (72.75, 86.34)

78.65 (69.54, 85.05)

0.252

 Lymphocytes (%)

25 (15.8, 38.8)

25.75 (16.38, 39.53)

24.4 (15.2, 38.62)

27.2 (17.8, 39.5)

22.3 (14.05, 37.15)

26.9 (17.8, 39.73)

0.132

 Hemoglobin (g/dL)

12.7 (11.45, 13.8)

12.7 (11.23, 13.78)

12.4 (11.35, 13.57)

12.95 (11.7, 14.16)

12.5 (11.38, 13.8)

12.75 (11.45, 13.8)

0.05

 Platelets (K/uL)

209 (171, 257.88)

197.5 (165.75, 260.25)

219.75 (169.88, 276.75)

210 (170.88, 256.25)

209.25 (176.5, 253.38)

205 (172.75, 246.38)

0.274

 RDW (%)

13.6 (13, 14.49)

13.65 (13.1, 14.35)

13.65 (13.1, 14.7)

13.55 (12.9, 14.31)

13.5 (12.9, 14.5)

13.68 (13, 14.49)

0.299

 Calcium (mg/dL)

8.8 (8.4, 9.2)

8.8 (8.35, 9.2)

8.78 (8.4, 9.15)

8.9 (8.51, 9.3)

8.85 (8.33, 9.24)

8.85 (8.55, 9.15)

0.358

 Sodium (mEq/L)

139.5 (137.5, 142)

140 (137.75, 142)

139.5 (137, 141.5)

140 (137.5, 142)

139.5 (137.5, 142)

139.5 (137.88, 142)

0.858

 Potassium (mEq/L)

4 (3.7, 4.3)

3.95 (3.7, 4.3)

4.05 (3.75, 4.34)

4 (3.7, 4.31)

4 (3.75, 4.3)

3.92 (3.7, 4.3)

0.701

 Creatinine (mg/dL)

0.9 (0.75, 1.1)

0.95 (0.75, 1.1)

0.9 (0.75, 1.15)

0.9 (0.7, 1.1)

0.9 (0.74, 1.1)

0.9 (0.75, 1.1)

0.123

 BUN (mg/dL)

16.5 (13, 21.5)

17 (13, 21.5)

16.5 (13, 21.5)

16 (12, 20.5)

17 (12.5, 22.12)

16.5 (13, 21)

0.679

 Bilirubin (mg/dL)

0.6 (0.4, 0.9)

0.6 (0.4, 0.9)

0.6 (0.4, 0.8)

0.6 (0.5, 0.9)

0.6 (0.4, 0.9)

0.7 (0.5, 0.9)

0.685

 ALT c

1.28 (1.18, 1.45)

1.3 (1.15, 1.48)

1.3 (1.18, 1.45)

1.28 (1.15, 1.45)

1.28 (1.18, 1.45)

1.28 (1.17, 1.4)

0.929

 AST d

1.41 (1.3, 1.58)

1.42 (1.32, 1.6)

1.41 (1.28, 1.57)

1.41 (1.28, 1.58)

1.41 (1.3, 1.59)

1.41 (1.32, 1.56)

0.711

 PT (s)

12.4 (11.5, 13.8)

12.5 (11.6, 13.75)

12.4 (11.62, 14.07)

12.32 (11.5, 14)

12.3 (11.51, 13.65)

12.4 (11.36, 13.69)

0.685

 APTT (s)

27.95 (25.45, 30.85)

28.2 (25.32, 30.9)

28.1 (25.7, 30.65)

27.7 (25.59, 31.97)

27.95 (25, 30.35)

27.92 (25.98, 30.63)

0.537

 TG (mg/dL)

94 (71, 138)

100 (74, 147.25)

99 (72, 140)

93 (67.5, 139.25)

98 (70.75, 133.75)

91 (69.25, 120.38)

0.438

 ABG (mg/dL)

124 (103, 155)

96 (89, 109)

108 (98, 119)

121 (111, 137)

136.5 (125.75, 153.25)

181 (156, 239.5)

< 0.001

 HbA1C (%)

5.7 (5.4, 6.3)

6 (5.6, 6.7)

5.7 (5.38, 6.1)

5.7 (5.4, 6.3)

5.6 (5.3, 6)

5.7 (5.2, 6.68)

< 0.001

Events

       

 Los ICU (days)

3.32 (1.73, 7.59)

2.07 (1.14, 4.95)

3.22 (1.66, 6.65)

3.31 (1.78, 6.84)

4.24 (1.92, 8.09)

4.76 (2.04, 9.61)

< 0.001

 Los hospital (days)

7.63 (4.05, 14.82)

5.78 (3.65, 12)

7.66 (3.92, 13.15)

7.02 (4.46, 13.64)

8.72 (4.92, 16.27)

9.75 (4.76, 16.8)

0.002

 30-day mortaility (%)

195 (19)

23 (11)

22 (11)

36 (17)

39 (19)

75 (36)

< 0.001

 1-year mortality (%)

323 (31)

52 (25)

48 (24)

65 (31)

58 (28)

100 (49)

< 0.001

 Lung infection (%)

168 (16)

26 (13)

25 (12)

30 (14)

36 (18)

51 (25)

168 (16)

Medications

       

 Vasoactive drugs

148 (14)

29 (14)

30 (15)

27 (13)

35 (17)

27 (13)

0.748

 RRT

20 (2)

3 (1)

5 (2)

5 (2)

6 (3)

1 (0)

0.334

 Invasive ventilation

384 (37)

70 (34)

80 (39)

70 (33)

88 (43)

76 (37)

0.242

 Vent time (hours)

40.34 (22.5, 108.87)

34.6 (18.87, 139.9)

37.7 (22, 92)

43.51 (27.15, 112.75)

41.9 (25.5, 97.09)

43.23 (22.45, 123.53)

0.921

  1. a Continuous data is presented as median (interquartile range), whereas categorical data is presented as frequency (percentage)
  2. b SHR: Q1 (≤ 0.234), Q2 (0.234–0.892), Q3 (0.892–1.033), Q4 (1.033–1.228), Q5 (>1.228)
  3. c ALT in the table is the value after logarithmic transformation
  4. d AST in the table is the value after logarithmic transformation
  5. Abbreviation: SHR, stress hyperglycemia ratio; GCS, Glasgow coma scale; APSIII, acute physiology score III; SAPSII, simplifed acute physiological score II; SOFA, sequential organ failure assessment; OASIS, oxford acute severity of illness score; MI, myocardial infarct; CHF, congestive heart failure; RD, rheumatic disease; PVD, peripheral vascular disease; CPD, chronic pulmonary disease; HR: heart rate; AP: arterial pressure; RR: respiratory rate; Temp: body temperature; WBC, white blood cell count; RDW, red cell distribution width; BUN, blood urea nitrogen; ALT, alanine aminotransferase; AST, aspartate aminotransferase; PT, prothrombin time; APTT, activated partial thromboplastin time; TG, triglycerides; ABG, admission blood glucose; HbA1C, glycated hemoglobin A1
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us